13F Pro Quality Score

26.4/100

Rank #2,504 of 2,879 stocks

View Materials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

52.0/100

Profitability

10.7/100

Balance Sheet

6.0/100

Earnings Quality

30.0/100

Free Cash Flow

16.5/100

Institutional Flow

70.6/100

Revenue Scale

24.9/100

Dilution Risk

34.3/100

AMTX Stock Analysis & AI Quality Score

AI stock analysis and institutional research for AEMETIS, INC (AMTX), a Materials sector company. 13F Pro's AI-powered ranking engine scores AMTX at 26.4/100 on a 32-signal composite quality model, placing it at rank #2,504 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (6.0) and profitability (10.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 34.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), AEMETIS, INC reports quarterly revenue of $54.6M, net income of $-21.7M, free cash flow of $-17.1M. Top institutional holders of AMTX by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, Grantham, Mayo, Van Otterloo & Co., MARSHALL WACE, LLP, based on the most recent SEC filings. AMTX trades on the Nasdaq exchange and files with the SEC under CIK 738214. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AMTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AEMETIS, INC directly from SEC EDGAR. AEMETIS, INC's 13F Pro composite quality score has ranged between 15 and 32 since 2021, currently 26.4 — a declining long-term trajectory across 30 quarterly and live scoring snapshots.

Fun facts about AEMETIS, INC

Quirks, history, and lore behind AMTX — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. clean energy company · listed on Nasdaq · headquartered in California · operates in the biofuels sector.
  • 2
    The Numbers
    A small-cap company with annual revenue in the range of tens of millions of dollars — big ambitions, tight margins, and a stock that keeps traders on their toes.
  • 3
    The History
    Founded in the mid-2000s, it was built around the idea that farm waste and energy crops could replace fossil fuels — long before that was fashionable.
  • 4
    The Secret
    It runs a biodiesel and ethanol biorefinery in India as well as operations in California, making it one of the few U.S. biofuel companies with a serious international footprint.
  • 5
    The Lore
    Its California plant in Keyes produces low-carbon ethanol from corn, while its India operations tap sugarcane — a two-continent renewable fuel play under one tiny ticker.
  • 6
    The Giveaway
    The name blends "advanced energy" into a single word, the ticker is AMTX, and its CEO Eric McAfee has championed cellulosic and low-carbon biofuels since the company's founding.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$54.6M

Net Income

Q1 2026

$-21.7M

Free Cash Flow

Q1 2026

$-17.1M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-26.2% YoY
$197.6MFY 2025
FY21 $211.9MFY23 $77.2MFY24 $267.6MFY25 $197.6M

Net Income

+12.0% YoY
$-77.0MFY 2025
FY21 $-47.1MFY23 $-46.4MFY24 $-87.5MFY25 $-77.0M

Operating Income

+7.9% YoY
$-37.2MFY 2025
FY21 $-15.8MFY23 $-37.4MFY24 $-40.4MFY25 $-37.2M

EPS (Diluted)

+33.0% YoY
$-1.28FY 2025
FY21 $-1.54FY23 $-1.22FY24 $-1.91FY25 $-1.28

Total Assets

+0.2% YoY
$259.8MFY 2025
FY21 $160.8MFY23 $243.4MFY24 $259.3MFY25 $259.8M

Total Debt

+12.9% YoY
$381.8MFY 2025
FY21 $188.8MFY23 $294.7MFY24 $338.1MFY25 $381.8M

Op. Cash Flow

+109.9% YoY
$3.3MFY 2025
FY21 $-20.6MFY23 $13.8MFY24 $-32.9MFY25 $3.3M

AI Insight: AMTX Financial Trends

Debt surged to $405M in Q1 2026 while equity deteriorated to -$321M, leaving Aemetis deeply insolvent with no quarter of positive net income across the entire period.

Total debt rose steadily from $309M in Q2 2024 to $405M in Q1 2026, a $96M increase over six quarters with no sign of stabilization.

Operating losses narrowed from -$14M in Q2 2024 to -$2M in Q4 2025 before widening again to -$6M in Q1 2026.

Operating cash flow turned positive at $3M in Q3 2025 and $6M in Q4 2025, the only two quarters of positive OCF in the dataset, then reversed to -$11M in Q1 2026.

Equity deteriorated from -$249M in Q2 2024 to -$321M in Q1 2026, deepening insolvency by $72M over the period.

Debt jumped $23M in a single quarter to $405M in Q1 2026 — the largest quarterly increase in the dataset — raising refinancing risk.

Revenue declined to $43M in Q1 2025 and Q4 2025, the lowest readings; Q1 2026 recovery to $55M warrants monitoring for sustainability.

OCF swung sharply from +$6M in Q4 2025 to -$11M in Q1 2026 — the worst reading in two quarters — reversing a tentative improvement.

AI Insight: AMTX Ratio Trends

AEMETIS remains deeply unprofitable across all metrics, though Q4 2025 showed a sharp but potentially seasonal margin improvement that has since partially reversed.

Operating margin improved dramatically from -36.3% in Q1 2025 to -5.7% in Q4 2025, then deteriorated to -11.6% in Q1 2026.

ROA swung from -40.5% in Q1 2025 to -8.2% in Q4 2025, but rebounded negatively to -32.1% in Q1 2026, signaling no sustained recovery.

ROIC remained severely negative, ranging from -13.2% in Q4 2025 to -90.6% in Q2 2024, indicating persistent capital destruction.

Q4 2025's anomalously strong margins (-5.7% OpMargin, -12.3% NPM) warrant scrutiny — likely seasonal or one-off, not structural improvement.

Net profit margin remains deeply negative at -39.8% in Q1 2026, far worse than operating margin, signaling heavy below-the-line financing costs.

ROE and D/E are unavailable across all periods, obscuring leverage risk for a capital-intensive biofuels operator.

Get alerted when AMTX's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for AEMETIS, INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put AMTX on your watchlist

Track score changes the day AEMETIS, INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is AMTX a good stock to buy?

13F Pro's AI-powered analysis of AEMETIS, INC (AMTX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Materials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AMTX are available on the AMTX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own AMTX?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AMTX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of AEMETIS, INC's investment landscape.